The latest developments from suppliers of ingredients, development and manufacturing services, and related technologies for pharmaceutical and biopharmaceutical development and production.
The Biomedical Advanced Research and Development Authority (BARDA), part of the office of Assistant Secretary for Preparedness and Response (ASPR) at the US Department of Health and Human Services (HHS), has entered into a $354-million agreement...
The latest news from CDMOs, CMOs, and suppliers featuring WuXi Advanced Therapies, WuXi Biologics, Catalent, Sharp, Colorcon, and Rentschler Biopharma.
Biologics Manufacturing
WuXi Biologics To Build New Biomanufacturing Facility in US WuXi...
Thermo Fisher Scientific is expanding capacity for viral vector development and manufacturing services with the construction of a new commercial manufacturing site in Plainville, Massachusetts. The $180-million project will more...
The latest news from CDMOs, CMOs, and suppliers featuring MilliporeSigma, Evonik, Marken, Ori Biotech and CellGenix.
Biologics Manufacturing
MilliporeSigma Launches Next Tool of Bioprocessing Software Suite Millipore Sigma has launched the next...
The latest from CDMOs, CMOs, and suppliers in COVID-19 projects featuring Catalent, Sterling Pharma, ABL, and Singota.
Chemicals/Chemical API Manufacturing
Sterling Begins Hydroxychloroquine Production in the...
The latest from CDMOs and suppliers in COVID-19 efforts featuring Seqens, Catalent, MilliporeSigma, Recipharm, Fujifilm Diosynth, AMRI, and Ajinomoto Bio-Pharma.
Chemicals/Chemical API Manufacturing
Seqens Supports Potential COVID-19...
The latest news from CDMOs, CMOs, and suppliers featuring Seqens, Adare Pharmaceuticals, AGC Biologics, Avid Bioservices, Avantor, Kindeva, and Univercells.
Chemicals/Chemical API Manufacturing
Seqens To Expand Flow-Chemistry CapabilitiesSeqens...
Sartorius has closed its $825-million acquisition of select life-science businesses of Danaher Corporation, a Washington, D.C.-headquartered science and technology company. Danaher divested the businesses to satisfy regulatory requirements as part...
Lonza and Moderna, a clinical-stage biopharmaceutical company developing messenger RNA (mRNA) therapeutics and vaccines, have formed a 10-year pact to enable manufacturing of up to one billion doses per year of Moderna’s mRNA vaccine (mRNA-1273)...
Evonik, a specialty and fine chemicals producer, plans to invest EUR 25 million ($27 million) to expand its facilities in Dossenheim and Hanau, Germany to support contract manufacturing of active pharmaceutical ingredients (APIs) and advanced...
The latest from CDMOs, CMOs, and suppliers in COVID-19 efforts featuring Ology Bioservices, Univercells, AGC Biologics, Cytovance, and LabVantage.
Biologics Manufacturing
DOD Awards Ology Bioservices $27.3 M for Cell Platform Development The...
The latest news from CDMOs, CMOs, and suppliers featuring WuXi Biologics, Catalent, Stevanato, Wasdell, and Evotec.
Chemicals/Chemical API Manufacturing
Evotec, leon-nanodrugs Enter Pact for Nanomedicine Evotec, a Hamburg, Germany-based...
The Janssen Pharmaceutical Companies of Johnson & Johnson (J&J) have signed separate agreements with Emergent BioSolutions, a Gaithersburg, Maryland-based specialty biopharmaceutical company and contract manufacturer, and Catalent for the...
The latest from CDMOs, CMOs, and suppliers in supporting COVID-19 efforts featuring MilliporeSigma, Cytiva, Emergent BioSolutions, Recipharm, Kaneka, Marken, Croda, and Wavelength Pharmaceuticals.
Chemicals/Chemical API Manufacturing
Kaneka To...
Merck KGaA has announced plans to invest EUR 100-million ($108-million) for a second commercial viral vector and gene-therapy manufacturing facility in Carlsbad, California for the CDMO service offerings of its life-science business. The new...
